Camrelizumab for Injection

Carrelizumab can be used to treat patients with Hodgkin’s lymphoma, hepatocellular carcinoma, non-small cell lung cancer, esophageal squamous cell carcinoma and nasopharyngeal carcinoma.
Patients with allergic reactions to the active ingredients or excipients of this product are contraindicated.
Clinical symptoms and signs should be closely observed after medication, including chills, fever, chest tightness, itching, rash, hypotension and hypotension… Details 
Comprehensive interpretation of carrelizumab

Effects and effects:
This product can be used to treat patients with Hodgkin’s lymphoma, hepatocellular carcinoma, non-small cell lung cancer, esophageal squamous cell carcinoma and nasopharyngeal carcinoma.
Dosage and administration:
This product must be used under the guidance of a physician with experience in tumor treatment. Recommended dose: Classical Hodgkin’s lymphoma, second-line esophageal squamous cell carcinoma, nasopharyngeal carcinoma (monotherapy): 200 mg/time, intravenous injection once every 2 weeks until disease progression or intolerable toxicity occurs. Advanced hepatocellular carcinoma: 3 mg/kg, intravenous injection once every 3 weeks until disease progression or intolerable toxicity occurs. First-line treatment for advanced or metastatic non-small cell lung cancer, locally recurrent or metastatic nasopharyngeal carcinoma, locally advanced/recurrent or metastatic esophageal squamous cell carcinoma: 200 mg/time, intravenous injection once every 3 weeks until disease progression or tolerable toxicity occurs. When carrelizumab is administered in combination with chemotherapy, carrelizumab should be given by intravenous drip first, and chemotherapy should be given at least 30 minutes later. The same drugs produced by different manufacturers may have inconsistent instructions. If you find inconsistencies in the drug instructions before taking the drug, please consult a doctor or pharmacist in time.
Drug contraindications:
Driving is prohibited if you are allergic to this product.
Related dosage forms:
Injection